Outcomes of pharmacists’ interventions in the collaborative care of patients with diabetes

Authors

  • Azuka C. Oparah Department of Clinical Pharmacy & Pharm. Practice, University of Benin, Nigeria
  • Akintoye J. Famakinde Federal Medical Centre, Owo, Ondo State Nigeria
  • Adebaya OJ2

Keywords:

Clinic setting, diabetes, pharmaceutical care, pharmacists, Nigeria

Abstract

Objectives: To describe and assess the impact of pharmacists’ interventions in the collaborative care of patients with diabetes in a Nigerian hospital.
Methods: Selected patients were randomised into control and intervention groups. The control group received usual hospital care. The intervention group received an additional pharmaceutical care package. After three months, patients’ knowledge of the disease management, adherence to the treatment regimen, and blood glucose levels were determined and compared.
Results: There were 99 participants (49 in the control group and 50 in the intervention group). Interventions improved patients’ awareness of self-management. Mean preprandial blood glucose before intervention was 9.04 ± 3.469 mmol/L and 5.62 ± 1.243 mmol/L after, (p < 0.0001) while peak post-prandial levels were 12.44 ± 4.581 mmol/L versus 7.60 ± 1.824 mmol/L respectively, (p < 0.0001).
Conclusion: Pharmacists’ active involvement in the collaborative care of patients with diabetes improved patient outcomes.

References

American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care, volume 28, supplement 1, January 2005

Clemmer TP, Spuhler VJ, Berwick DM, Nolan TW (1998). Cooperation: the foundation of improvement. Ann Intern Med 128:1004-1009.

Cranor CW, Bunting BA, and Christensen DB (2003). The Asheville Project: Long-term clinical and economic outcomes for community pharmacy diabetes care program. J Am Pharm Assoc; 43(2): 173–184.

Fagin CM (1992). Collaboration between nurses and physicians: no longer a choice. Acad Med 67:295- 303.

Garrett DG and Martin LA (2003). The Asheville Project: Participants' perceptions of factors contributing to the success of a patient self-management diabetes program J Am Pharm Assoc; 43(2):185–190.

Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, and Anderson HG Jr (2002). A retrospective cohort analysis of the clinical effectiveness of a physician- pharmacist collaborative drug therapy management diabetes clinic. Pharmacother. ;22 (10):1294–1300.

Jaber A, Halapy H, Fernet M, Tummalapalli S, and Diwakaran H (1996). Evaluation of a pharmaceutical care model on diabetes management. The Annals of Pharmacother. ;30(3):238–243.

McDonough RP, Doucette WR (2001). Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc 41(5): 682-692.

Papa PA, Rector C, Stone C (1998). Interdisciplinary collaborative training for school- based health professionals. J Sch Health 68:415-419.

Poulton BC, West MA (1998). Effective multidisciplinary teamwork in primary health care. J Adv Nurs 18:918-925.

Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter L et al (1999). Guidelines for management of hypertension. Report of the third working party of the British Hypertension Society. J Hum Hyperten 13:569-592.

Rothman R, Malone R, Bryant B, Horlen C, and Pignone M (2003). Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. Am J Med Quality;18(2):51–58

Royal Pharmaceutical Society. Guidelines for community pharmacists on the care of patients with diabetes. Diabetes task force. London: The Society; 1999.

Singhal PK, Gupchup GV, Raisch DW, Schommer JC, and Holdsworth MT (2002). Impact of pharmacists’directive guidance behaviors on patient satisfaction. J Am Pharm Assoc.;42(3):407–412.

UK prospective diabetes study group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes. UKPDS 33. Lancet 1998;352:837-853.

UK prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;317:703-713.

Umland ME. Pharmaceutical Care and the Patient with Diabetes: Interventions to Help Control Diabetes and Its Related Comorbidities. Pharmacy Times - Diabetes Issue. Available at https://secure.pharmacytimes.com/ lessons/200410-04.asp Accessed 06/10/07.

Downloads

How to Cite

Oparah, A. C., Famakinde, A. J., & OJ2, A. (2015). Outcomes of pharmacists’ interventions in the collaborative care of patients with diabetes. Pharmacy Education, 9. Retrieved from https://pharmacyeducation.fip.org/pharmacyeducation/article/view/271

Issue

Section

Research Article